Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Incline Therapeutics
Redwood City, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
IONSYS completed Phase III trials and had prior approvals in the US and EU. At time of acquisition by The Medicines Company, it awaited supplemental regulatory approval due to new safety features. No additional clinical results as an independent company after acquisition.[1][3]
- Therapeutic areas
- Other
- Modalities
- Drug-device combination (fentanyl iontophoretic transdermal system)
- Industry
- Biotech
02
Partnerships
Cadence Pharmaceuticals held an option agreement to acquire Incline prior to its sale to The Medicines Company.[8]
Beyond the preview
Go deeper on Incline Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Incline Therapeutics.